Author: Spindler P1, Bohlmann K2, Straub HB2, Vajkoczy P3, Schneider UC3
1Department of Neurosurgery, Charité University Hospital, Berlin, Luisenstraße 64, 10117, Germany. Electronic address: email@example.com.
2Epilepsy-Centrum Berlin-Brandenburg, Bernau, Germany.
3Department of Neurosurgery, Charité University Hospital, Berlin, Germany.
Date published: 2019 Apr 3
Other: Volume ID: 69 , Pages: 77-79 , Special Notes: doi: 10.1016/j.seizure.2019.04.001. [Epub ahead of print] , Word Count: 196
PURPOSE: Vagus nerve stimulation (VNS) is well established in the treatment of epilepsy and disorders of depression. The prevalence of depression is high in patients with epilepsy, but still it remains unclear how patients with a comorbidity of epilepsy and symptoms of depression respond to VNS.
METHODS: We investigated 59 patients with different subtypes of disorders of depression as a comorbidity of epilepsy, who underwent VNS-surgery. Before and one year after VNS surgery, the severity of symptoms of depression was evaluated by a psychiatrist using Montgomery-Åsberg Depression Rating Scale (MADRS) and Beck-Depressions-Inventory (BDI). Response towards epilepsy was measured by a seizure reduction of at least 50%.
RESULTS: Symptoms of depression ameliorated in response to VNS in the overall of all patients MADRS 29 to 18 (p < 0,001) and BDI 24 to 14 (p < 0,001) and all subtypes of disorders of depression. Seizure reduction of at least 50% was achieved in two out of three of all patients two years after VNS.
CONCLUSION: We were able to show the beneficial effect of VNS in the treatment of patients with pharmacoresistant epilepsy and a comorbidity of symptoms of depression.
Copyright © 2019 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
PMID: 30986721 DOI: 10.1016/j.seizure.2019.04.001